Aparna S, Ved Devendra Kumar, Lalitha S, Venkatasubramanian Padma
Centre For Pharmacognosy, Pharmaceutics, Pharmacology, Centre For Ism Informatics, Institute of Ayurveda and Integrative Medicine (Foundation for Revitalization of Local Health Traditions), Bangalore, Karnataka, India.
Anc Sci Life. 2012 Jul;32(1):3-10. doi: 10.4103/0257-7941.113790.
Daśamūla (DM) is a top-traded group of medicinal plants used by the Ayurvedic industry. Through literature survey and analysis, this article has enlisted the botanical sources of DM, as correlated by several scholars. Such a list is not available from any single, earlier publication. It brings to light the confusion that exists in terms of botanical sources correlated to Ayurvedic entities. There is quite a bit of difference in the botanical correlation, parts, and substitutes reported in the different scholarly works, particularly for Pṛṣṇiparṇī, and Agnimantha. For e.g., is Uraria picta the original intended Pṛṣṇiparṇī, as the Ayurvedic Formulary of India (AFI) stipulates or is it U. lagopoidiodes or Desmodium gangeticum as other scholars report? While AFI provides two botanical correlations to Agnimantha in its two editions, namely Premna integrifolia and Clerodendrum phlomidis, other scholars correlate it to other Premna and Clerodendrum species. Why has AFI provided stem bark and whole plant as substitutes for roots of DM? Are substitutes recommended by AFI only for ecological or practical convenience or is there an Ayurvedic or pharmacological explanation for the same?
There are many species used in the name of Daśamūla,, in this article all the species are listed out to find the differences in the usage of the drugs.
Ayurveda texts and lexicons along with the texts which have done correlation work were considered to arrive at a list of various species used as Dasmula.
Since neither the methodology nor the logic behind the correlation have been discussed in these scholarly works, including the AFI, the same is not available for analysis or scrutiny. Such a list as provided in this article can form an essential base for a much needed systematic approach at etymological analysis, botanical correlation, and further scientific work to establish legitimacy of substitutes prescribed.
十大根类药（DM）是阿育吠陀产业中交易量大的一组药用植物。通过文献调研与分析，本文列出了多位学者所关联的DM的植物来源。此前尚无任何单一出版物提供过这样一份清单。它揭示了与阿育吠陀实体相关的植物来源方面存在的混乱情况。不同学术著作中报道的植物关联、部位及替代品存在相当大的差异，尤其是对于菝葜叶铁线莲和藿香叶绿绒蒿。例如，按照《印度阿育吠陀配方》（AFI）的规定，长叶狸尾豆是原本所指的菝葜叶铁线莲，还是如其他学者所报道的平卧狸尾豆或恒河山蚂蝗呢？虽然AFI在其两个版本中为藿香叶绿绒蒿提供了两种植物关联，即全缘臭黄荆和毛叶臭牡丹，但其他学者将其与其他臭黄荆属和臭牡丹属物种相关联。为什么AFI提供茎皮和全株作为DM根部的替代品呢？AFI推荐这些替代品仅仅是出于生态或实际便利，还是对此有阿育吠陀或药理学方面的解释呢？
有许多物种以十大根类药之名使用，本文列出所有这些物种以找出药物使用上的差异。
考虑阿育吠陀文献和词典以及已进行关联工作的文献，以得出用作十大根类药的各种物种清单。
由于包括AFI在内的这些学术著作均未讨论关联背后的方法或逻辑，因此无法对其进行分析或审查。本文提供的这样一份清单可为词源分析、植物关联以及进一步的科学工作以确立所开替代品的合法性所需的系统方法奠定重要基础。
